ITEM 1.
|
SCHEDULE OF INVESTMENTS
|
Investment Portfolio | as of December 31, 2012 (Unaudited) |
Shares
|
Value ($)
|
||||||||
Common Stocks 98.5%
|
|||||||||
Consumer Discretionary 22.3%
|
|||||||||
Auto Components 1.4%
|
|||||||||
BorgWarner, Inc.* (a)
|
33,672
|
2,411,588
|
|||||||
Tenneco, Inc.* (a)
|
57,906
|
2,033,080
|
|||||||
4,444,668
|
|||||||||
Hotels, Restaurants & Leisure 2.4%
|
|||||||||
Darden Restaurants, Inc. (a)
|
61,032
|
2,750,712
|
|||||||
Panera Bread Co. "A"* (a)
|
30,208
|
4,797,937
|
|||||||
7,548,649
|
|||||||||
Household Durables 3.0%
|
|||||||||
Jarden Corp.
|
73,719
|
3,811,272
|
|||||||
Newell Rubbermaid, Inc.
|
105,489
|
2,349,240
|
|||||||
Toll Brothers, Inc.*
|
105,807
|
3,420,741
|
|||||||
9,581,253
|
|||||||||
Internet & Catalog Retail 0.7%
|
|||||||||
Priceline.com, Inc.* (a)
|
3,459
|
2,148,731
|
|||||||
Leisure Equipment & Products 1.2%
|
|||||||||
Polaris Industries, Inc. (a)
|
46,694
|
3,929,300
|
|||||||
Media 1.0%
|
|||||||||
Cinemark Holdings, Inc. (a)
|
123,553
|
3,209,907
|
|||||||
Multiline Retail 1.1%
|
|||||||||
Family Dollar Stores, Inc. (a)
|
57,812
|
3,665,859
|
|||||||
Specialty Retail 8.5%
|
|||||||||
Advance Auto Parts, Inc.
|
26,200
|
1,895,570
|
|||||||
Ascena Retail Group, Inc.*
|
152,958
|
2,828,193
|
|||||||
Children's Place Retail Stores, Inc.*
|
54,462
|
2,412,122
|
|||||||
DSW, Inc. "A" (a)
|
48,377
|
3,177,885
|
|||||||
Guess?, Inc. (a)
|
75,189
|
1,845,138
|
|||||||
PetSmart, Inc. (a)
|
62,638
|
4,280,681
|
|||||||
Ross Stores, Inc.
|
66,832
|
3,618,953
|
|||||||
Ulta Salon, Cosmetics & Fragrance, Inc.
|
37,407
|
3,675,612
|
|||||||
Urban Outfitters, Inc.* (a)
|
85,862
|
3,379,528
|
|||||||
27,113,682
|
|||||||||
Textiles, Apparel & Luxury Goods 3.0%
|
|||||||||
Carter's, Inc.*
|
58,452
|
3,252,854
|
|||||||
Deckers Outdoor Corp.* (a)
|
40,651
|
1,637,015
|
|||||||
Hanesbrands, Inc.* (a)
|
131,306
|
4,703,381
|
|||||||
9,593,250
|
|||||||||
Consumer Staples 4.3%
|
|||||||||
Food Products 3.0%
|
|||||||||
Green Mountain Coffee Roasters, Inc.* (a)
|
63,571
|
2,629,297
|
|||||||
McCormick & Co., Inc. (a)
|
60,425
|
3,838,800
|
|||||||
Mead Johnson Nutrition Co.
|
49,573
|
3,266,365
|
|||||||
9,734,462
|
|||||||||
Household Products 1.3%
|
|||||||||
Church & Dwight Co., Inc. (a)
|
74,664
|
3,999,750
|
|||||||
Energy 8.9%
|
|||||||||
Energy Equipment & Services 5.7%
|
|||||||||
Cameron International Corp.*
|
55,473
|
3,132,006
|
|||||||
Core Laboratories NV (a)
|
18,540
|
2,026,607
|
|||||||
Dresser-Rand Group, Inc.*
|
53,037
|
2,977,497
|
|||||||
Ensco PLC "A" (a)
|
39,200
|
2,323,776
|
|||||||
FMC Technologies, Inc.*
|
97,541
|
4,177,681
|
|||||||
Oil States International, Inc.*
|
48,591
|
3,476,200
|
|||||||
18,113,767
|
|||||||||
Oil, Gas & Consumable Fuels 3.2%
|
|||||||||
Alpha Natural Resources, Inc.* (a)
|
145,068
|
1,412,962
|
|||||||
Pioneer Natural Resources Co. (a)
|
38,230
|
4,074,936
|
|||||||
Range Resources Corp. (a)
|
56,538
|
3,552,282
|
|||||||
Ultra Petroleum Corp.* (a)
|
70,128
|
1,271,421
|
|||||||
10,311,601
|
|||||||||
Financials 8.8%
|
|||||||||
Capital Markets 2.8%
|
|||||||||
Affiliated Managers Group, Inc.* (a)
|
29,591
|
3,851,268
|
|||||||
Invesco Ltd. (a)
|
98,699
|
2,575,057
|
|||||||
Lazard Ltd. "A" (a)
|
86,745
|
2,588,471
|
|||||||
9,014,796
|
|||||||||
Commercial Banks 1.1%
|
|||||||||
Signature Bank* (a)
|
48,748
|
3,477,682
|
|||||||
Diversified Financial Services 1.3%
|
|||||||||
Portfolio Recovery Associates, Inc.* (a)
|
39,609
|
4,232,618
|
|||||||
Insurance 1.2%
|
|||||||||
W.R. Berkley Corp. (a)
|
97,666
|
3,685,915
|
|||||||
Real Estate Investment Trusts 0.6%
|
|||||||||
Digital Realty Trust, Inc. (REIT) (a)
|
28,165
|
1,912,122
|
|||||||
Real Estate Management & Development 1.2%
|
|||||||||
CBRE Group, Inc. "A"*
|
149,972
|
2,984,443
|
|||||||
Realogy Holdings Corp.* (a)
|
18,080
|
758,637
|
|||||||
3,743,080
|
|||||||||
Thrifts & Mortgage Finance 0.6%
|
|||||||||
Ocwen Financial Corp.*
|
57,158
|
1,977,095
|
|||||||
Health Care 13.8%
|
|||||||||
Biotechnology 3.8%
|
|||||||||
Alexion Pharmaceuticals, Inc.*
|
35,297
|
3,311,212
|
|||||||
Alkermes PLC* (a)
|
105,210
|
1,948,489
|
|||||||
ARIAD Pharmaceuticals, Inc.* (a)
|
67,524
|
1,295,110
|
|||||||
Incyte Corp., Ltd.* (a)
|
93,949
|
1,560,493
|
|||||||
Regeneron Pharmaceuticals, Inc.* (a)
|
24,210
|
4,141,605
|
|||||||
12,256,909
|
|||||||||
Health Care Equipment & Supplies 1.2%
|
|||||||||
Thoratec Corp.*
|
102,712
|
3,853,754
|
|||||||
Health Care Providers & Services 5.9%
|
|||||||||
AmerisourceBergen Corp. (a)
|
105,289
|
4,546,379
|
|||||||
Catamaran Corp.* (a)
|
122,486
|
5,770,316
|
|||||||
Centene Corp.*
|
53,247
|
2,183,127
|
|||||||
DaVita HealthCare Partners, Inc.*
|
38,493
|
4,254,631
|
|||||||
Humana, Inc.
|
29,489
|
2,023,830
|
|||||||
18,778,283
|
|||||||||
Life Sciences Tools & Services 1.5%
|
|||||||||
Agilent Technologies, Inc.
|
117,340
|
4,803,899
|
|||||||
Pharmaceuticals 1.4%
|
|||||||||
Pacira Pharmaceuticals, Inc.* (a)
|
256,719
|
4,484,881
|
|||||||
Industrials 16.7%
|
|||||||||
Aerospace & Defense 1.4%
|
|||||||||
BE Aerospace, Inc.*
|
90,713
|
4,481,222
|
|||||||
Commercial Services & Supplies 0.9%
|
|||||||||
Stericycle, Inc.*
|
32,916
|
3,070,075
|
|||||||
Electrical Equipment 3.4%
|
|||||||||
General Cable Corp.* (a)
|
109,346
|
3,325,212
|
|||||||
Rockwell Automation, Inc.
|
56,430
|
4,739,556
|
|||||||
The Babcock & Wilcox Co.
|
107,913
|
2,827,320
|
|||||||
10,892,088
|
|||||||||
Machinery 4.6%
|
|||||||||
Joy Global, Inc. (a)
|
63,933
|
4,077,647
|
|||||||
Manitowoc Co., Inc. (a)
|
245,453
|
3,848,703
|
|||||||
Valmont Industries, Inc.
|
24,147
|
3,297,273
|
|||||||
WABCO Holdings, Inc.* (a)
|
51,891
|
3,382,774
|
|||||||
14,606,397
|
|||||||||
Professional Services 3.2%
|
|||||||||
IHS, Inc. "A"* (a)
|
38,350
|
3,681,600
|
|||||||
Robert Half International, Inc. (a)
|
75,126
|
2,390,510
|
|||||||
Verisk Analytics, Inc. "A"* (a)
|
79,553
|
4,057,203
|
|||||||
10,129,313
|
|||||||||
Road & Rail 1.6%
|
|||||||||
Kansas City Southern (a)
|
63,644
|
5,313,001
|
|||||||
Trading Companies & Distributors 1.6%
|
|||||||||
United Rentals, Inc.* (a)
|
110,126
|
5,012,936
|
|||||||
Information Technology 14.9%
|
|||||||||
Communications Equipment 1.4%
|
|||||||||
F5 Networks, Inc.* (a)
|
19,977
|
1,940,765
|
|||||||
Harris Corp. (a)
|
53,360
|
2,612,506
|
|||||||
4,553,271
|
|||||||||
Computers & Peripherals 2.0%
|
|||||||||
Western Digital Corp.
|
147,964
|
6,286,990
|
|||||||
Internet Software & Services 1.3%
|
|||||||||
Equinix, Inc.* (a)
|
19,581
|
4,037,602
|
|||||||
IT Services 1.8%
|
|||||||||
Syntel, Inc. (a)
|
47,025
|
2,520,070
|
|||||||
VeriFone Systems, Inc.* (a)
|
111,485
|
3,308,875
|
|||||||
5,828,945
|
|||||||||
Semiconductors & Semiconductor Equipment 2.3%
|
|||||||||
Analog Devices, Inc.
|
34,817
|
1,464,403
|
|||||||
ARM Holdings PLC (ADR) (a)
|
73,246
|
2,770,896
|
|||||||
Avago Technologies Ltd.
|
102,570
|
3,247,367
|
|||||||
7,482,666
|
|||||||||
Software 6.1%
|
|||||||||
Citrix Systems, Inc.*
|
52,909
|
3,478,767
|
|||||||
Concur Technologies, Inc.* (a)
|
18,451
|
1,245,811
|
|||||||
Informatica Corp.* (a)
|
74,244
|
2,251,078
|
|||||||
Intuit, Inc. (a)
|
76,407
|
4,546,216
|
|||||||
MICROS Systems, Inc.* (a)
|
64,397
|
2,733,009
|
|||||||
Red Hat, Inc.*
|
63,859
|
3,381,973
|
|||||||
TIBCO Software, Inc.*
|
84,073
|
1,850,447
|
|||||||
19,487,301
|
|||||||||
Materials 7.8%
|
|||||||||
Chemicals 4.7%
|
|||||||||
Albemarle Corp.
|
38,567
|
2,395,782
|
|||||||
CF Industries Holdings, Inc. (a)
|
21,916
|
4,452,454
|
|||||||
Rockwood Holdings, Inc. (a)
|
75,458
|
3,732,153
|
|||||||
Westlake Chemical Corp. (a)
|
57,403
|
4,552,058
|
|||||||
15,132,447
|
|||||||||
Containers & Packaging 1.1%
|
|||||||||
Crown Holdings, Inc.*
|
91,554
|
3,370,103
|
|||||||
Metals & Mining 1.0%
|
|||||||||
Allegheny Technologies, Inc. (a)
|
62,079
|
1,884,719
|
|||||||
Walter Energy, Inc. (a)
|
40,080
|
1,438,070
|
|||||||
3,322,789
|
|||||||||
Paper & Forest Products 1.0%
|
|||||||||
Schweitzer-Mauduit International, Inc. (a)
|
83,166
|
3,245,969
|
|||||||
Telecommunication Services 1.0%
|
|||||||||
Wireless Telecommunication Services
|
|||||||||
SBA Communications Corp. "A"* (a)
|
45,497
|
3,231,197
|
|||||||
Total Common Stocks (Cost $263,887,084)
|
315,100,225
|
||||||||
Exchange-Traded Fund 0.5%
|
|||||||||
SPDR S&P Biotech (Cost $1,577,619)
|
17,036
|
1,497,635
|
|||||||
Securities Lending Collateral 45.1%
|
|||||||||
Daily Assets Fund Institutional, 0.20% (b) (c)
(Cost $144,389,820)
|
144,389,820
|
144,389,820
|
|||||||
Cash Equivalents 1.5%
|
|||||||||
Central Cash Management Fund, 0.15% (b)
(Cost $4,724,237)
|
4,724,237
|
4,724,237
|
% of
Net Assets
|
Value ($)
|
|||||
Total Investment Portfolio (Cost $414,578,760) †
|
145.6
|
465,711,917
|
||||
Other Assets and Liabilities, Net
|
(45.6)
|
(145,749,597)
|
||||
Net Assets
|
100.0
|
319,962,320
|
For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements.
|
|
*
|
Non-income producing security.
|
†
|
The cost for federal income tax purposes was $415,167,404. At December 31, 2012, net unrealized appreciation for all securities based on tax cost was $50,544,513. This consisted of aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost of $62,685,862 and aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value of $12,141,349.
|
(a)
|
All or a portion of these securities were on loan. The value of all securities loaned at December 31, 2012 amounted to $144,179,260, which is 45.1% of net assets.
|
(b)
|
Affiliated fund managed by Deutsche Investment Management Americas Inc. The rate shown is the annualized seven-day yield at period end.
|
(c)
|
Represents collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates.
|
ADR: American Depositary Receipt
|
|
REIT: Real Estate Investment Trust
|
|
S&P: Standard & Poor's
|
|
SPDR: Standard & Poor's Depositary Receipt
|
Assets
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Common Stocks(d)
|
$ | 315,100,225 | $ | — | $ | — | $ | 315,100,225 | ||||||||
Exchange-Traded Fund
|
1,497,635 | — | — | 1,497,635 | ||||||||||||
Short-Term Investments(d)
|
149,114,057 | — | — | 149,114,057 | ||||||||||||
Total
|
$ | 465,711,917 | $ | — | $ | — | $ | 465,711,917 |
There have been no transfers between fair value measurement levels during the period ended December 31, 2012.
|
(d)
|
See Investment Portfolio for additional detailed categorizations.
|
ITEM 2.
|
CONTROLS AND PROCEDURES
|
(a) The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
|
|
(b) There have been no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.
|
|
ITEM 3.
|
EXHIBITS
|
Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.
|
Registrant:
|
DWS Mid Cap Growth Fund, a series of DWS Investment Trust
|
By:
|
/s/W. Douglas Beck
W. Douglas Beck
President
|
Date:
|
February 19, 2013
|
By:
|
/s/W. Douglas Beck
W. Douglas Beck
President
|
Date:
|
February 19, 2013
|
By:
|
/s/Paul Schubert
Paul Schubert
Chief Financial Officer and Treasurer
|
Date:
|
February 19, 2013
|
|
1.
|
I have reviewed this report on Form N-Q of DWS Mid Cap Growth Fund, a series of DWS Investment Trust;
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
3.
|
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
|
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
5.
|
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
By:
|
/s/W. Douglas Beck
W. Douglas Beck
President
|
Date:
|
February 19, 2013
|
|
1.
|
I have reviewed this report on Form N-Q of DWS Mid Cap Growth Fund, a series of DWS Investment Trust;
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
3.
|
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
|
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
5.
|
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
By:
|
/s/Paul Schubert
Paul Schubert
Chief Financial Officer and Treasurer
|
Date:
|
February 19, 2013
|